Recorded on July 22, 2021.
PathGen Diagnostik Teknologi disrupts the molecular diagnostics market for cancer through inclusive, robust, and affordable platforms. With a strong ecosystem of academic-business-government-community partnership, PathGen seeks to democratize precision medicine, especially in developing countries, and enable molecular diagnostics for all.
Extreme Tech Challenge Global Finals: Startup Pitches Part 2 – PathGen
From the collection XTC Challenge 2021
October 27-29, 2025
San Francisco
ONE-WEEK BUNDLE FLASH SALE
Founder Bundle Offer: Land your investor and sharpen your pitch. Save 15% when you bring 4-9 founders.
Investors Bundle Offer: Discover your next breakout startup. Save 20% when you bring 4-9 investors.
Bundle offer ends October 3.
